Abstract
The major purpose of a couple at the first infertility appointment is to get a healthy baby as soon as possible. From diagnosis and decision on which assisted reproduction technique (ART) and controlled ovarian stimulation, to the selection of which embryo to transfer, the dedicated team of physicians and embryologists puts all efforts to shorten the time to pregnancy and live birth. Time seems thus central in assisted reproduction, and we can conveniently use it as a measure of treatment efficiency. How can we measure time to live birth? What timelines do we need to consider to evaluate efficiency? In this paper, we will discuss the importance of “Time” as a fundamental parameter for measuring ART success.
Similar content being viewed by others
References
Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. N Engl J Med. 2009;360(3):236–43. https://doi.org/10.1056/NEJMoa0803072.
Maheshwari A, McLernon D, Bhattacharya S. Cumulative live birth rate: time for a consensus? Hum Reprod. 2015;263. https://doi.org/10.1093/humrep/dev263.
U. Department of Health, H. Services, C. for Disease Control, N. Center for Chronic Disease Prevention, and H. Promotion, “2019 Assisted reproductive technology fertility clinic and national summary report.” [Online]. n.d. Available: www.cdc.gov/art/reports. Accessed 18 Aug 2022.
de Geyter C, Calhaz-Jorge C, Kupka MS, Wyns C, Mocunu W, Motrenko T, Scaravelli G, Smeenk J, Vidakovic S, Goossens V. The European IVF.monitoring Consortium (EIM) for European Society of Human Reproduction and Embryology (ESHRE). ART in Europe, 2015: results generated from European registries by ESHRE. Hum Reprod Open. 2020. https://doi.org/10.1093/hropen/hoz038.
Fischer C, Scott TR. Three simple metrics to define in vitro fertilization success rates. Fertil Steril. 2020;114(1):6–8. https://doi.org/10.1016/j.fertnstert.04.056.
te Velde E, Eijkemans R, Habbema H. Variation in couple fecundity and time to pregnancy, an essential concept in human reproduction. Lancet. 2000;355(9219):1928–9. https://doi.org/10.1016/S0140-6736(00)02320-5.
Sunkara SK, Zheng W, D’Hooghe T, Longobardi S, Boivin J. Time as an outcome measure in fertility-related clinical studies: long-awaited. Hum Reprod. 2020;35(8):1732–9. https://doi.org/10.1093/humrep/deaa138.
Duffy JMN, AlAhwany H, Bhattacharya S, Collura B, Curtis C, Evers JLH, Farquharson RG, Franik S, Giudice LC, Khalaf Y, Knijnenburg JML, Leeners B, Legro RS, Lensen S, Vazquez-Niebla Jc, Mavrelos D, Mol BWJ, Niederberger C, Ng EHY, Otter SD, Puscasiu L, Rautakallio-Hokkanen S, Repping S, Sarris I, Simpson JL, Strandell A, Strawbridge, Torrance HL, Vail A, van Wely M, Vercoe MA, Vuong NL, Wang AY, Wang R, Wilkinson J, Youssef MA, Farquhar CM. Core Outcome Measure for Infertility Trials (COMMIT) initiative. Developing a core outcome set for future infertility research: an international consensus development study. Hum Reprod. 2020;35(12):2725–34. https://doi.org/10.1093/humrep/deaa241.
Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomás C, Fauser BCJM. Improving the patient’s experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod. 2008;24(4):764–74. https://doi.org/10.1093/humrep/den468.
Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, can der Veen F, van Wely M. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23(5):560–79. https://doi.org/10.1093/humupd/dmx017.
Ho VNA, Braam SC, Pham Td, Mol BW, Vuong LN. The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count. Hum Reprod. 2019;34(6):1055–64. https://doi.org/10.1093/humrep/dez060.
Cecchino GN, Roque M, Cerrillo M, Filho RR, Chiamba FS, Hatty JH, García-Velasco JA. DuoStim cycles potentially boost reproductive outcomes in poor prognosis patients. Gynecol Endocrinol. 2021;37(6):519–22. https://doi.org/10.1080/09513590.2020.1822804.
Boltz MW, Sanders JN, Simonsen SE, Stanford JB. Fertility treatment, use of in vitro fertilization, and time to live birth based on initial provider type. J Am Board Fam. 2017;30(2):230–8. https://doi.org/10.3122/jabfm.2017.02.160184.
Bosch E, Bulletti C, Copperman AB, Fanchin R, Yarali H, Petta CA, Polyzos NP, Shaapiro D, Ubaldi FM, Velasco JAG, Longobardi S, D’Hooghe T, Humaidan P, Delphi TTP Consensus Group. How time to healthy singleton delivery could affect decision-making during infertility treatment: a Delphi consensus. Reprod Biomed Online. 2019;38(1):118–30. https://doi.org/10.1016/j.rbmo.2018.09.019.
Harper J, Jackson E, Sermon K, Aitken RJ, Harbottle S, Mocanu E, Hardarson T, Mathur R, Viville S, Vail A, Lundin K. Adjuncts in the IVF laboratory: where is the evidence for ‘add-on’ interventions? Hum Reprod. 2017;32(3):485–549. https://doi.org/10.1093/humrep/dex004.
Penzias A, Bendikson K, Butts S, Coutifaris C, Falcone T, Fossum G, Gitlin S, Gracia C, Hansen K, La Barbera A, Mersereau J, Odem R, Paulson R, Pfeifer S, Pisarska M, Rebar R, Reindollar R, Rosen M, Sandlow J, Vernon M, Widra E. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Fertil Steril. 2018;109(3):429–36. https://doi.org/10.1016/j.fertnstert.2018.01.002.
Sacchi L, Albani E, Cesana A, Smeraldi A, Parini V, Fabiani M, Poli M, Capalbo A, Levi-Setti PE. Preimplantation genetic testing for aneuploidy improves clinical, gestational, and neonatal outcomes in advanced maternal age patients without compromising cumulative live-birth rate. J Assist Reprod Genet. 2019;36(12):2493–504. https://doi.org/10.1007/s10815-019-01609-4.
Reignier A, Lefebvre T, Loubersac S, Lammers J, Barriere P, Freour T. Time-lapse technology improves total cumulative live birth rate and shortens time to live birth as compared to conventional incubation system in couples undergoing ICSI. J Assist Reprod Genet. 2021;38:917–23. https://doi.org/10.1007/s10815-021-02099-z/Published.
Glujovsky D, Farquhar C. Cleavage-stage or blastocyst transfer: what are the benefits and harms? Fertil Steril. 2016;106(2):244–50. https://doi.org/10.1016/j.fertnstert.2016.06.029.
Clua E, Rodríguez I, Arroyo G, Racca A, Martínez F, Polyzos NP. Blastocyst versus cleavage embryo transfer improves cumulative live birth rates, time and cost in oocyte recipients: a randomized controlled trial. Reprod Biomed Online. 2022;44(6):995–1004. https://doi.org/10.1016/j.rbmo.2022.01.001.
Ferrick L, Lee YSL, Gardner DK. Reducing time to pregnancy and facilitating the birth of healthy children through functional analysis of embryo physiology. Biol Reprod. 2019;101(6):1124–39. https://doi.org/10.1093/biolre/ioz005.
Price SA, Sumithran P, Prendergast LA, Nankervis AJ, Permezel M, Proietto J. Time to pregnancy after a prepregnancy very-low-energy diet program in women with obesity: substudy of a randomized controlled trial. Fertil Steril. 2020;114(6):1256–62. https://doi.org/10.1016/j.fertnstert.2020.06.033.
Vanegas JC, Chavarro JE, Williams PL, Ford JB, Toth TL, Hauser R, Gaskins AJ. Discrete survival model analysis of a couple’s smoking pattern and outcomes of assisted reproduction. Fertil Res Pract. 2017;3(1):5. https://doi.org/10.1186/s40738-017-0032-2.
Gleicher N, Kushnir VA, Albertini DF, Barad DH. Improvements in IVF in women of advanced age. J Endocrinol. 2016;230(1):F1–6. https://doi.org/10.1530/JOE-16-0105.
Murugesu S, Kasaven LS, Petrie A, Vaseekaran A, Jones BP, Bracewell-Milnes T, Barcroft JF, Grewal KJ, Getreu N, Galazis N, Sorbi F, Saso S, Ben-Nagi J. Does advanced paternal age affect outcomes following assisted reproductive technology? A systematic review and meta-analysis. Reprod BioMed Online. 2022;45(2):283–331. https://doi.org/10.1016/j.rbmo.2022.03.031.
Author information
Authors and Affiliations
Contributions
MM and CEP drafted the manuscript. All authors contributed through literature search and discussion.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Marques, M., Rodrigues, P., Aibar, J. et al. Time to live birth: towards a common agreement. J Assist Reprod Genet 40, 997–1001 (2023). https://doi.org/10.1007/s10815-023-02790-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-023-02790-3